RBC Capital analyst Ben Hendrix maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $58.00.

Amazon is winning the U.S. price wars, leaving Walmart and Target behind for the eighth consecutive year. The e-commerce ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $68.4, with a high ...

An ambulance service boss has said he is confident its performance will improve this winter. Dan Ainsworth, from the North ...

A breast cancer vaccine could be closer to reality, according to Cleveland Clinic, as its researchers have announced some ...

Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria Resubmission includes new pivotal data which confirm ...

Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activity M ...

Good afternoon, and welcome to Fractyl Health's Third Quarter Financial Results and Business Updates Call. As a reminder, this conference call is being recorded. [Operator Instructions]. I will now ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Morgans healthcare analyst Scott Power notes that while the S&P/ASX 200 Health Care index is down 1.4% over the past ... Read ...

In the midst of catastrophic humanitarian suffering for more than two million Palestinians — half of them children, the Israeli occupation army continued, for the 406th consecutive day, to pound and ...